샘플 요청 목록

 카트 문의
시장보고서
상품코드
1941903

제약 미생물학 품질관리 검사 시장 규모, 점유율과 동향 분석 보고서 : 제품 유형별, 검사 유형별, 기술별, 용도별, 지역별, 부문 예측(2026-2033년)

Pharmaceutical Microbiology QC Testing Market Size, Share & Trends Analysis Report By Product, By Test Type, By Technique, By Application, By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

제약 미생물학 품질관리 검사 시장 요약

세계의 제약 미생물학 품질관리 검사 시장 규모는 2025년에 40억 3,000만 달러로 추정되며, 2033년까지 106억 달러에 달할 것으로 예측됩니다.

2026-2033년 연평균 복합 성장률(CAGR) 12.98%를 나타낼 것으로 예측됩니다. 기술 발전, 규제 압력, 환자 안전과 제품 품질에 대한 관심 증가로 인해 이 산업은 괄목할 만한 성장을 이룩했습니다.

자주 묻는 질문

  • 제약 미생물학 품질관리 검사 시장 규모는 어떻게 예측되나요?
  • 제약 미생물학 품질관리 검사 시장의 성장 요인은 무엇인가요?
  • 제약 미생물학 품질관리 검사 시장의 주요 조사 방법과 범위는 무엇인가요?
  • 제약 미생물학 품질관리 검사 시장의 경쟁 구도는 어떻게 되나요?

목차

제1장 조사 방법과 범위

제2장 개요

제3장 시장 변수, 동향 및 범위

제4장 제품별 비즈니스 분석

제5장 검사 유형별 비즈니스 분석

제6장 기술별 비즈니스 분석

제7장 용도별 비즈니스 분석

제8장 제품, 검사 유형, 기술 및 용도별 지역별 추정·동향 분석

제9장 경쟁 구도

KSA

Pharmaceutical Microbiology QC Testing Market Summary

The global pharmaceutical microbiology QC testing market size was estimated at USD 4.03 billion in 2025 and is projected to reach USD 10.60 billion by 2033, growing at a CAGR of 12.98% from 2026 to 2033. The industry is experiencing significant growth, driven by a combination of technological advancements, regulatory pressures, and an increasing emphasis on patient safety and product quality.

Global Pharmaceutical Microbiology QC Testing Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical microbiology QC testing market report on the basis of product, test type, technique, application, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Reagents & Kits
  • Accessories
  • Software
  • Test Type Outlook (Revenue, USD Million, 2021-2033)
  • Traditional/Conventional Testing
  • Rapid Testing
  • Technique Outlook (Revenue, USD Million, 2021-2033)
  • Growth-based Testing
  • Nucleic Acid-based Testing
  • Cellular Component-based Testing
  • Viability-based Testing
  • Other Techniques
  • Application Outlook (Revenue, USD Million, 2021-2033)
  • Bioburden testing
  • Sterility testing
  • Environmental monitoring
  • Endotoxin testing
  • Pyrogen testing
  • Mycoplasma testing
  • Microbial identification
  • Other applications
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Test Type Segment
    • 1.2.3. Technique Segment
    • 1.2.4. Application Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
    • 1.9.1. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Increasing focus on quality control and rising microbiology testing needs
    • 3.3.2. Technological advancements in rapid testing
  • 3.4. Market Restraint Analysis
    • 3.4.1. Expensive equipment and technology hinder market adoption
    • 3.4.2. Complex regulations slow down the approval and implementation process
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Pharmaceutical Microbiology QC Testing Market: Product Movement Analysis
  • 4.3. Global Pharmaceutical Microbiology QC Testing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2021 - 2033 (USD Million)
  • 4.5. Reagents & Kits
    • 4.5.1. Reagents & Kits Market, 2021 - 2033 (USD Million)
  • 4.6. Accessories
    • 4.6.1. Accessories Market, 2021 - 2033 (USD Million)
  • 4.7. Software
    • 4.7.1. Software Market, 2021 - 2033 (USD Million)

Chapter 5. Test Type Business Analysis

  • 5.1. Test Type Segment Dashboard
  • 5.2. Global Pharmaceutical Microbiology QC Testing Market: Test Type Movement Analysis
  • 5.3. Global Pharmaceutical Microbiology QC Testing Market Size & Trend Analysis, by Test Type, 2021 to 2033 (USD Million)
  • 5.4. Traditional/Conventional Testing
    • 5.4.1. Traditional/Conventional Testing Market, 2021 - 2033 (USD Million)
  • 5.5. Rapid Testing
    • 5.5.1. Rapid Testing Market, 2021 - 2033 (USD Million)

Chapter 6. Technique Business Analysis

  • 6.1. Technique Segment Dashboard
  • 6.2. Global Pharmaceutical Microbiology QC Testing Market: Technique Movement Analysis
  • 6.3. Global Pharmaceutical Microbiology QC Testing Market Size & Trend Analysis, by Technique, 2021 to 2033 (USD Million)
  • 6.4. Growth-based Testing
    • 6.4.1. Growth-based Testing Market, 2021 - 2033 (USD Million)
  • 6.5. Nucleic Acid-based Testing
    • 6.5.1. Nucleic Acid-based Testing Market, 2021 - 2033 (USD Million)
  • 6.6. Cellular Component-based Testing
    • 6.6.1. Cellular Component-based Testing Market, 2021 - 2033 (USD Million)
  • 6.7. Viability-based Testing
    • 6.7.1. Viability-based Testing Market, 2021 - 2033 (USD Million)
  • 6.8. Other Techniques
    • 6.8.1. Other Techniques Market, 2021 - 2033 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. Global Pharmaceutical Microbiology QC Testing Market: Application Movement Analysis
  • 7.3. Global Pharmaceutical Microbiology QC Testing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 7.4. Bioburden testing
    • 7.4.1. Bioburden testing Market, 2021 - 2033 (USD Million)
  • 7.5. Sterility testing
    • 7.5.1. Sterility testing Market, 2021 - 2033 (USD Million)
  • 7.6. Environmental monitoring
    • 7.6.1. Environmental monitoring Market, 2021 - 2033 (USD Million)
  • 7.7. Endotoxin testing
    • 7.7.1. Endotoxin testing Market, 2021 - 2033 (USD Million)
  • 7.8. Pyrogen testing
    • 7.8.1. Pyrogen testing Market, 2021 - 2033 (USD Million)
  • 7.9. Mycoplasma testing
    • 7.9.1. Mycoplasma testing Market, 2021 - 2033 (USD Million)
  • 7.10. Microbial identification
    • 7.10.1. Microbial identification Market, 2021 - 2033 (USD Million)
  • 7.11. Other Applications
    • 7.11.1. Other Applications Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Estimates & Trend Analysis by Product, Test Type, Technique, & Application

  • 8.1. Regional Market Dashboard
  • 8.2. Global Pharmaceutical Microbiology QC Testing Market Share By Region, 2025 & 2033
  • 8.3. North America
    • 8.3.1. North America Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Germany Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. UK Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. South Korea Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Australia Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Thailand Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Target Disease Prevalence
      • 8.7.5.5. Kuwait Pharmaceutical Microbiology QC Testing Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Company Market Position Analysis, 2025
  • 9.3. Participant's Overview
    • 9.3.1. Thermo Fisher Scientific, Inc
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Merck KGaA
      • 9.3.2.1. Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. BD
      • 9.3.3.1. Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. bioMerieux SA
      • 9.3.4.1. Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Danaher
      • 9.3.5.1. Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Sartorius AG
      • 9.3.6.1. Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Rapid Micro Biosystems, Inc.
      • 9.3.7.1. Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Charles River Laboratories
      • 9.3.8.1. Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. HiMedia Laboratories
      • 9.3.9.1. Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Hardy Diagnostics
      • 9.3.10.1. Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제